8-K: Abacus Global Management Reports Record Q3, Raises 2025 Outlook

Sentiment:

Quarterly Results


Abacus Global Management announced its tenth consecutive quarter of strong earnings growth, record revenue, and an increased 2025 outlook.

Capital raiseCompleted a $50 million securitized asset-backed rated note of life insurance assets to institutional investors.This transaction is structured as an above-investment-grade collateralized note.It marks the beginning of a scalable and recurring funding mechanism for the company.
Better than expectedReported record revenue growth of 124% year-over-year.Achieved GAAP net income of $7.1 million, a significant turnaround from a prior-year net loss.Adjusted net income increased 60% year-over-year.Adjusted EBITDA grew 127% year-over-year.Increased the full-year 2025 Adjusted net income outlook above the prior range, now expecting 72% to 81% year-over-year growth.

Summary

  • Reported results for the third quarter ended September 30, 2025, marking the tenth consecutive quarter of earnings growth.
  • Total revenue grew 124% year-over-year to $63.0 million, compared to $28.1 million in the prior-year period.
  • Origination capital deployment increased by 10% for the quarter to $102.4 million, compared to $93.2 million in the prior-year period.
  • The number of policies held at quarter end totaled 522, up from 278 as of September 30, 2024.
  • GAAP net income attributable to shareholders was $7.1 million, a significant improvement from a net loss of $5.1 million in the prior-year period.
  • Adjusted net income (non-GAAP) increased 60% year-over-year to $23.6 million, compared to $14.7 million in the prior-year period.
  • Adjusted diluted earnings per share for Q3 2025 was $0.24, up from $0.20 in the prior-year period.
  • Adjusted EBITDA (non-GAAP) for Q3 2025 increased 127% to $37.9 million, compared to $16.7 million in the prior-year period.
  • Adjusted EBITDA margin (non-GAAP) for Q3 2025 was 60.2%, in line with the prior-year period.
  • Annualized return on invested capital (ROIC) (non-GAAP) for Q3 2025 was 21%, and Annualized Return on Equity (ROE) (non-GAAP) was 22%.
  • Annualized Turnover Ratio (non-GAAP) for Q3 2025 was 2.0x, in-line with the long-term target of 1.5x to 2.0x.
  • Average Realized Gain (non-GAAP) for Q3 2025 was 37%, compared to 26.3% as first reported in Q2 2025.
  • Abacus was added to the Russell 2000 and 3000 Indexes, effective September 22, 2025.
  • Subsequent to quarter end, the company announced the strategic acquisition of AccuQuote, an online life insurance brokerage company.
  • Most recently, Abacus announced a $50 million securitized asset-backed rated note of life insurance assets, structured as an above-investment-grade collateralized note to institutional investors.
  • As of September 30, 2025, the Company had cash and cash equivalents of $86.4 million and balance sheet policy assets of $424.7 million.
  • The full-year 2025 outlook for Adjusted net income has been raised to between $80 million and $84 million, implying growth of 72% to 81% compared to full year 2024 Adjusted net income of $46.5 million.

Sentiment

Score: 9

Explanation: The filing reports exceptionally strong financial results across all key metrics, including record revenue growth, significant increases in GAAP and Adjusted Net Income and EBITDA, and a raised full-year outlook. Strategic acquisitions and a successful capital raise further bolster a very positive outlook.

Positives

  • Achieved its tenth consecutive quarter of strong earnings growth.
  • Reported record total revenue growth of $63.0 million, up 124% year-over-year.
  • GAAP Net Income attributable to shareholders was $7.1 million, a significant improvement from a $5.1 million net loss in the prior-year period.
  • Adjusted Net Income increased 60% year-over-year to $23.6 million.
  • Adjusted EBITDA grew 127% year-over-year to $37.9 million.
  • Increased its full-year 2025 outlook for Adjusted Net Income to between $80 million and $84 million, representing 72% to 81% year-over-year growth.
  • Origination capital deployment expanded by 10% to $102.4 million.
  • The number of policies held increased significantly to 522 from 278 year-over-year.
  • Achieved strong Annualized Return on Invested Capital (ROIC) of 21% and Annualized Return on Equity (ROE) of 22%.
  • Average Realized Gain improved to 37% for Q3 2025, up from 26.3% in Q2 2025.
  • Was added to the Russell 2000 and 3000 Indexes, enhancing visibility and access to institutional investors.
  • Completed the strategic acquisition of AccuQuote, expanding its financial services platform and digital origination funnel.
  • Successfully completed a $50 million securitized asset-backed rated note transaction, establishing a scalable and recurring funding mechanism.

Negatives

  • Increased operating costs and interest expense partially offset higher revenues, though overall GAAP net income was positive.

Risks

  • Loss reserves are based on estimates and may be inadequate to cover actual losses.
  • Failure to properly price insurance policies.
  • Geographic concentration of business.
  • Cyclical nature of the industry.
  • Impact of regulation on business.
  • Effects of competition on business.
  • Failure of relationships with independent agencies.
  • Failure to meet investment objectives.
  • Inability to raise capital on favorable terms or at all.
  • Effects of acts of terrorism.
  • Effectiveness of control environment, including the identification of control deficiencies.

Future Outlook

Abacus Global Management has increased its full-year 2025 outlook for Adjusted net income to a range of $80 million to $84 million, up from the prior outlook of $74 million to $80 million. This revised guidance implies a year-over-year growth of 72% to 81% compared to the $46.5 million Adjusted net income reported for full year 2024.

Management Comments

  • "The third quarter represents our tenth consecutive quarter of earnings growth, driven by disciplined execution and robust demand for our longevity-based assets, uncorrelated to traditional markets at a time when investors are increasingly focused on diversification."
  • "We are once again increasing our full-year 2025 expectations for adjusted earnings, now projecting year-over-year growth of 72 to 81%."
  • "Our acquisition of AccuQuote further expands and strengthens our financial services platform."
  • "Most recently, we achieved another key milestone with the sale of $50 million in securitized life insurance assets, structured as an investment-grade rated collateralized note to institutional investors."
  • "Together, these achievements reinforce our momentum, scalability, and visibility as we continue building a new asset class and creating long-term value for all Abacus stakeholders."

Industry Context

The announcement highlights Abacus's strong performance in the alternative asset management space, particularly with longevity-based assets. This aligns with a broader industry trend where investors are increasingly seeking diversification and assets uncorrelated to traditional markets, especially given current market volatility and interest in alternative investment strategies. The acquisition of AccuQuote and the securitized note transaction demonstrate strategic moves to expand market reach and secure scalable funding within this growing sector.

Comparison to Industry Standards

  • The filing does not provide specific comparable companies, projects, or results for direct benchmarking against industry peers.
  • Abacus's "tenth consecutive quarter of earnings growth" and 124% year-over-year revenue growth are indicative of strong performance, potentially outpacing many traditional financial services firms.
  • The Annualized Turnover Ratio of 2.0x is in-line with the company's previously announced long-term target of 1.5x to 2.0x, suggesting consistent operational efficiency within its specific asset class.
  • The Average Realized Gain of 37% for Q3 2025, up from 26.3% in Q2 2025, suggests improving asset performance within its longevity-based portfolio, which is a key metric for this specialized industry.
  • The inclusion in the Russell 2000 and 3000 Indexes indicates growing market capitalization and recognition within the broader investment community, aligning with benchmarks for mid-cap and small-cap growth companies.

Stakeholder Impact

  • Shareholders/Investors: Positive impact due to strong financial performance, increased earnings outlook, strategic acquisitions, and a new scalable funding mechanism, which could lead to increased share value and investor confidence. Inclusion in Russell indexes enhances visibility and access.
  • Customers: The acquisition of AccuQuote expands the financial services platform and digital origination funnel, potentially offering more comprehensive solutions and broader access to longevity-based assets.

Next Steps

  • A webcast and conference call to discuss the results will be held on November 6, 2025, at 5:00 p.m. (Eastern Time).
  • The Company intends to post a new investor presentation to its Investor Relations Presentations section of its website on November 6, 2025.
  • Investors should monitor the Investor Relations section of the Company's website for important information.

Key Dates

DateDescription
2024-09-30Number of policies held in prior-year period.
2025-09-22Effective date of Abacus's addition to the Russell 2000 and 3000 Indexes.
2025-09-30End of the third quarter for which results are reported; cash and cash equivalents and balance sheet policy assets reported as of this date.
2025-11-06Date of the 8-K report and press release announcing Q3 2025 results; date of conference call; date Company intends to post new investor presentation.

Recommendation

strong buy

The company delivered exceptional Q3 2025 results, including record revenue growth of 124%, a significant turnaround to GAAP net income, and substantial increases in Adjusted Net Income and EBITDA. Management has raised its full-year 2025 Adjusted Net Income outlook, indicating strong confidence in continued growth (72-81% year-over-year). Strategic moves like the AccuQuote acquisition and the successful $50 million securitized note demonstrate effective capital deployment and a scalable funding strategy. These factors, combined with inclusion in major indexes, suggest strong operational momentum and a positive trajectory for the stock, making it a compelling "strong buy" for investors seeking growth in the alternative asset management sector.

Keywords

Abacus Global Management, ABL, NASDAQ, Q3 2025, financial results, earnings growth, revenue growth, adjusted net income, adjusted EBITDA, alternative asset management, longevity-based assets, AccuQuote acquisition, securitized notes, life insurance assets, Russell 2000, Russell 3000, financial services, corporate governance, risk management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.